Advertisement
Screener

ACHILLION PHARMACEUTICALS INC Basic Shares Outstanding (Weighted Average)

ACHILLION PHARMACEUTICALS INC Basic Shares Outstanding (Weighted Average)

ACHILLION PHARMACEUTICALS INC reported Basic Shares Outstanding (Weighted Average) of 136.69 million shares for the 3-month period ending 2016-12-31, per its 10-K filed 2017-02-23.

Discontinued › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2017-02-23

  • ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, basic for the quarter ending 2016-12-31 was 136.69M shares, a 0.10% increase year-over-year.
  • ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, basic for the quarter ending 2016-09-30 was 136.68M shares, a 0.18% increase year-over-year.
  • ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, basic for the quarter ending 2016-06-30 was 136.68M shares, a 16.06% increase year-over-year.
  • ACHILLION PHARMACEUTICALS INC weighted average number of shares outstanding, basic for the quarter ending 2016-03-31 was 136.64M shares, a 22.88% increase year-over-year.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 12 month
2016-12-31136.69M shares
10-K · filed 2017-02-23
136.69M shares
derived: average of 2 quarters · filed 2017-02-23
136.68M shares
derived: average of 3 quarters · filed 2017-02-23
136.67M shares
derived: average of 4 quarters · filed 2017-02-23
2016-09-30136.68M shares
10-K · filed 2017-02-23
136.68M shares
derived: average of 2 quarters · filed 2017-02-23
136.65M shares
10-Q · filed 2016-11-03
136.64M shares
derived: average of 4 quarters · filed 2017-02-23
2016-06-30136.68M shares
10-K · filed 2017-02-23
136.66M shares
derived: average of 2 quarters · filed 2017-02-23
136.63M shares
derived: average of 3 quarters · filed 2017-02-23
136.58M shares
derived: average of 4 quarters · filed 2017-02-23
2016-03-31136.64M shares
10-K · filed 2017-02-23
136.60M shares
derived: average of 2 quarters · filed 2017-02-23
136.55M shares
derived: average of 3 quarters · filed 2017-02-23
131.85M shares
derived: average of 4 quarters · filed 2017-02-23
2015-12-31136.56M shares
10-K · filed 2017-02-23
136.50M shares
derived: average of 2 quarters · filed 2017-02-23
130.26M shares
derived: average of 3 quarters · filed 2017-02-23
125.49M shares
derived: average of 4 quarters · filed 2017-02-23
2015-09-30136.44M shares
10-Q · filed 2016-11-03
127.10M shares
derived: average of 2 quarters · filed 2017-02-23
121.90M shares
10-Q · filed 2016-11-03
116.50M shares
derived: average of 4 quarters · filed 2017-02-23
2015-06-30117.77M shares
10-K · filed 2017-02-23
114.49M shares
derived: average of 2 quarters · filed 2017-02-23
109.85M shares
derived: average of 3 quarters · filed 2017-02-23
107.15M shares
derived: average of 4 quarters · filed 2017-02-23
2015-03-31111.20M shares
10-K · filed 2017-02-23
105.89M shares
derived: average of 2 quarters · filed 2017-02-23
103.60M shares
derived: average of 3 quarters · filed 2017-02-23
101.96M shares
derived: average of 4 quarters · filed 2017-02-23
2014-12-31100.58M shares
10-K · filed 2016-02-25
99.81M shares
derived: average of 2 quarters · filed 2016-02-25
98.88M shares
derived: average of 3 quarters · filed 2016-02-25
98.35M shares
derived: average of 4 quarters · filed 2016-02-25
2014-09-3099.03M shares
10-K · filed 2016-02-25
98.02M shares
derived: average of 2 quarters · filed 2016-02-25
97.62M shares
10-Q · filed 2015-11-05
2014-06-3097.02M shares
10-K · filed 2016-02-25
96.90M shares
derived: average of 2 quarters · filed 2016-02-25
2014-03-3196.79M shares
10-K · filed 2016-02-25